These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7030966)

  • 1. Platelet-activating factor (PAF-acether): molecular aspects of its release and pharmacological actions.
    Benveniste J; Jouvin E; Pirotzky E; Arnoux B; Mencia-Huerta JM; Roubin R; Vargaftig BB
    Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():121-6. PubMed ID: 7030966
    [No Abstract]   [Full Text] [Related]  

  • 2. Background and present status of research on platelet-activating factor (PAF-acether).
    Vargaftig BB; Chignard M; Benveniste J; Lefort J; Wal F
    Ann N Y Acad Sci; 1981; 370():119-37. PubMed ID: 7023317
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
    Keraly CL; Benveniste J
    Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-tissue interaction: role of platelet-activating factor (PAF-acether).
    Vargaftig BB; Chignard M; Lefort J; Benveniste J
    Agents Actions; 1980 Dec; 10(6):502-6. PubMed ID: 7270336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of platelet-activating factor (PAF-acether) from alveolar macrophages by the calcium ionophore A23187 and phagocytosis.
    Arnoux B; Duval D; Benveniste J
    Eur J Clin Invest; 1980 Dec; 10(6):437-41. PubMed ID: 6788561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.
    Benveniste J; Chignard M; Le Couedic JP; Vargaftig BB
    Thromb Res; 1982 Mar; 25(5):375-85. PubMed ID: 6803388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids.
    Polonsky J; Tencé M; Varenne P; Das BC; Lunel J; Benveniste J
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7019-23. PubMed ID: 6938950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
    McManus LM; Hanahan DJ; Demopoulos CA; Pinckard RN
    J Immunol; 1980 Jun; 124(6):2919-24. PubMed ID: 7373056
    [No Abstract]   [Full Text] [Related]  

  • 10. Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus.
    Camussi G; Tetta C; Coda R; Benveniste J
    Lab Invest; 1981 Mar; 44(3):241-51. PubMed ID: 7464048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes.
    Korth R; Riess H; Brehm G; Hiller E
    Thromb Res; 1986 Mar; 41(5):699-706. PubMed ID: 3961742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine].
    Benveniste J; Tencé M; Varenne P; Bidault J; Boullet C; Polonsky J
    C R Seances Acad Sci D; 1979 Nov; 289(14):1037-40. PubMed ID: 121258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D; Russo-Marie F; Benveniste J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
    Touqui L; Jacquemin C; Vargaftig BB
    Biochem Biophys Res Commun; 1983 Feb; 110(3):890-3. PubMed ID: 6838557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological modulation of platelet-activating factor (PAF) release from rabbit leucocytes. I. Role of cAMP.
    Bussolino F; Benveniste J
    Immunology; 1980 Jul; 40(3):367-76. PubMed ID: 6159308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M; Canciani MT; Mannucci PM
    Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.
    Touqui L; Chignard M; Jacquemin C; Wal F; Vargaftig BB
    Experientia; 1984 Apr; 40(4):374-7. PubMed ID: 6714369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paf-acether, an ether phospho-lipid with biological activity.
    Benveniste J
    Prog Clin Biol Res; 1988; 282():73-85. PubMed ID: 3071808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.